When was Scipher Medicine founded?

Scipher Medicine was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Scipher Medicine located?

Scipher Medicine is headquartered in Waltham, United States. It is registered at Waltham,Massachusetts.

Who is the current CEO of Scipher Medicine?

Alif Saleh of Scipher Medicine.

How many employees does Scipher Medicine have?

As of Aug 31, 2026, the latest employee count at Scipher Medicine is 51.

Is Scipher Medicine a funded company?

Scipher Medicine is a funded company, having raised a total of $233M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 01, 2015.

When was the latest funding round of Scipher Medicine?

Scipher Medicine's latest funding was a $***** Series D round on May 02, 2024, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $2.25B in funding in 2026 to date.

Where does Scipher Medicine rank among its competitors?

Scipher Medicine ranks 5th amongst 141 active competitors, of which 47 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was GRAIL, which secured $110M in Jun, 2026.

Who are the top competitors of Scipher Medicine?

Scipher Medicine's top competitors include Guardant Health, GRAIL and BillionToOne. Among them, GRAIL secured the most recent funding round in June, 2026.

Scipher Medicine - 2026 Company Profile, Team, Funding & Competitors

Scipher Medicine is a series D company based in Waltham (United States), founded in 2014 by Joseph Loscalzo, Albert-Laszlo Barabasi and Marcell Veidner. It operates as a Provider of precision medicine based on liquid biopsy test. Scipher Medicine has raised $233M in funding from investors like Northpond Ventures, Khosla Ventures and Cowen. The company has 141 active competitors, including 47 funded and 35 that have exited. Its top competitors include companies like Guardant Health, GRAIL and BillionToOne.

Company Details

Provider of precision medicine based on liquid biopsy test. The company's platform identifies which drug will work based on the patient's fundamental blood test report. It offers PrismRA is a blood-based test that predicts patients respond to anti-TNF therapy before the drug is prescribed. The company focuses on autoimmune, neurological, and cardiovascular diseases.

Website: sciphermedicine.com
Social
Registered Address: Waltham,Massachusetts

Key Metrics

Founded Year

2014

Location

Waltham, United States

Stage

Series D

Total Funding

$233M in 9 rounds

Latest Funding Round

Series D, May 02, 2024, $*****

Investors

Northpond Ventures & 15 more

Ranked

5^th among 141 active competitors

Employee Count

51 as on Aug 31, 2026

Investment & Acquisitions

CrossBridge & 2 more

Similar Companies

Guardant Health & 121 more

View Scipher Medicine's full profile

Scipher Medicine is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SCIPHER MEDICINE CIN: 463927710 , Belgium, Active	Dec 31, 1999	-	126 (As on Dec 31, 2022)	-

Scipher Medicine has raised a total funding of $233M over 9 rounds. Its first funding round was on Dec 01, 2015. Scipher Medicine has 16 institutional investors.

Here is the list of recent funding rounds of Scipher Medicine:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 02, 2024	7204871	Series D	4901944	3778702	6639757	8796147
Feb 24, 2022	3662520	Series D	9408385	1611256	3595826	Neuberger Berman & 10 more
Mar 15, 2021	4517683	Series C	7129765	8944215	aMoon & 1 more	Echo Health Ventures & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Scipher Medicine's funding rounds and investors

The founders of Scipher Medicine are Joseph Loscalzo, Albert-Laszlo Barabasi and Marcell Veidner. Reginald Seeto and Alif Saleh are the CEOs of Scipher Medicine.

Here are the details of Scipher Medicine's key team members:

Joseph Loscalzo: Co-Founder of Scipher Medicine.
Albert-Laszlo Barabasi: Co-Founder of Scipher Medicine.
Marcell Veidner: Co-Founder of Scipher Medicine.
Alif Saleh: CEO of Scipher Medicine.

View details of Scipher Medicine's Founder profiles and Board Members

Scipher Medicine's employee count trend

Scipher Medicine has 51 employees as of Aug 26. Here is Scipher Medicine's employee count trend over the years:

Employee count trend for Scipher Medicine

Uncover Scipher Medicine's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Scipher Medicine include Guardant Health, GRAIL and BillionToOne. Here is the list of Top 10 competitors of Scipher Medicine, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Lightspeed Venture Partners ... & 25 others	79/100
2nd	GRAIL 2016, Menlo Park (United States), Public	Developer of a screening platform for circulating tumor DNA to detect cancer	$2B	Arch Venture Partners, Hillhouse & 52 others	69/100
3rd	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100
4th	Foresight Diagnostics 2020, Aurora (United States), Acquired	Developer of minimally-invasive liquid biopsy test for the detection of cancer	$104M	Foresite Capital, Bluebird Ventures & 6 others	66/100
5th	Scipher Medicine 2014, Waltham (United States), Series D	Provider of precision medicine based on liquid biopsy test	$233M	Laurion Capital, Cowen & 14 others	65/100
6th	Saga Diagnostics 2016, Morrisville (United States), Acquired	Provider of tests for detection and analysis of circulating tumor DNA	$17.9M	Hadean Ventures, Segulah Medical Acceleration ... & 11 others	64/100
7th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	DFJ Growth, Orbimed & 19 others	64/100
8th	Volition 1995, Gembloux (Belgium), Public	Developer of cancer diagnostic tests	-	Namur Invest, Belgium & 1 others	61/100
9th	Naveris 2017, Waltham (United States), Acquired	Provider of blood tests for early cancer detection	$68.5M	Gurnet Point Capital, B-FLEXION & 3 others	60/100
10th	Codiak BioSciences 2015, Cambridge (United States), Public	Developer of exosome-based drugs and diagnostics for cancer treatment	$168M	Arch Venture Partners, Flagship Pioneering ... & 10 others	57/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Scipher Medicine's competitors? Click here to see the top ones

Scipher Medicine has acquired 3 companies including CrossBridge, CrossBridge and Yet2. Scipher Medicine has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 10, 2023	Acquisition	CrossBridge	1997	Wayne (United States)
Sep 01, 2015	Acquisition	CrossBridge	1997	Wayne (United States)
Dec 13, 2002	Acquisition	Yet2	1999	Waltham (United States)